MedTrace Logo

Olanzapine Versus Midazolam for Agitation

NCT03899506 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2019-05-13

No results posted yet for this study

Summary

The goal of this research investigation is to conduct a prospective observation of the comparative efficacy of midazolam versus olanzapine for the treatment of acute undifferentiated agitation in the emergency department.

Conditions

  • Agitation,Psychomotor

Interventions

DRUG

Olanzapine

Patients receiving Olanzapine per the ED protocol

DRUG

Midazolam

Patients receiving Midazolam per the ED protocol

Sponsors & Collaborators

  • Hennepin Healthcare Research Institute

    lead OTHER

Principal Investigators

  • Lauren Klein, MD · Hennepin County Medical Center, Minneapolis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-18
Primary Completion
2018-07-16
Completion
2018-07-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03899506 on ClinicalTrials.gov